← All Stocks
NASMED ÖZEL SAĞLIK HİZMETLERİ TİCARET A.Ş. stock logo

EGEPO NASMED ÖZEL SAĞLIK HİZMETLERİ TİCARET A.Ş. Stock

Sağlık

Nasmed Özel Sağlık Hizmetleri Ticaret A.Ş., sağlık sektöründe özel sağlık hizmetleri sunan bir şirkettir. Hastalara kaliteli ve güvenilir sağlık hizmetleri sağlamayı amaçlamaktadır.

19.77 TRY
+5.78%
2026-07-17
Sortino (21d)
5.11
Momentum 21d
+7.1%
Momentum 63d
+29.3%
Momentum 252d
+110.8%
Volatility 21d
+39.7%
E/P (TTM)
0.0131
P/B
3.27
Market Cap
6.9B TRY
Sector Comparison — Sağlık
Momentum 21g
Very Good4/4
EGEPO: +7.1%Sector avg: -0.9%
Momentum 63g
Very Good4/4
EGEPO: +29.3%Sector avg: +5.5%
Momentum 252g
Very Good4/4
EGEPO: +110.8%Sector avg: +30.6%
E/P (Q)
Very Weak1/4
EGEPO: 0.00Sector avg: 0.01
E/P (TTM)
Very Weak1/4
EGEPO: 0.01Sector avg: 0.05
PD/DD
Very Weak1/4
EGEPO: 3.27Sector avg: 1.88
Fiyat Grafiği
Historical Returns
1 Month
+3.9%
3 Months
+29.3%
6 Months
+122.1%
1 Year
+116.5%
3 Years
+204.9%
Quarterly Financials
Hasılat
EBITDA
Net Kar
Q2/24Q3/24Q4/24Q1/25Q2/25Q3/25Q4/25Q1/26
PeriodRevenueEBITDANet Income
2026 Q1438.3M-6.0M3.5M
2025 Q4383.8M22.1M100.5M
2025 Q3369.3M18.6M-11.6M
2025 Q2305.3M594K-2.2M
2025 Q1287.2M17.0M-3.3M
2024 Q4296.2M-127.0M-66.3M
2024 Q3287.2M17.9M66.3M
2024 Q2217.3M-10.6M-2.6M
E/P Ratio History
E/P (TTM)
2024 Q22024 Q32024 Q42025 Q12025 Q22025 Q32025 Q42026 Q1
PeriodP/E (TTM)TTM Net IncomeE/P QuarterlyE/P Annual (TTM)
2026 Q176.190.2M TRY0.00050.0131
2025 Q449.183.4M TRY0.02450.0204
2025 Q3-83.5M TRY-0.0028-0.0202
2025 Q2-5.5M TRY-0.0006-0.0015
2025 Q1-5.8M TRY-0.0010-0.0019
2024 Q4-25.0M TRY-0.0222-0.0084
2024 Q324.2104.6M TRY0.02620.0413
2024 Q242.555.2M TRY-0.00110.0235
Financial Metrics
Net Marj (%)
2024 Q22024 Q32024 Q42025 Q12025 Q22025 Q32025 Q42026 Q1
ROE (%)
2024 Q22024 Q32024 Q42025 Q12025 Q22025 Q32025 Q42026 Q1
PeriodNet MarginGross MarginROEROADebt/EquityRev. Growth (YoY)
2026 Q10.8%12.2%0.6%+52.6%
2025 Q426.2%14.6%17.4%+29.6%
2025 Q3-3.2%13.5%-2.7%-2.2%0.02+28.6%
2025 Q2-0.7%12.4%-0.5%-0.5%0.03+40.5%
2025 Q1-1.1%25.8%-0.9%-0.7%0.03+37.9%
2024 Q4-22.4%13.5%-19%-15.6%0.04+3.1%
2024 Q323.1%31.1%19.3%16%0.04+109.4%
2024 Q2-1.2%22.5%-0.9%-0.7%0.07+118.7%
P/B History
PD/DD
2024 Q22024 Q32024 Q42025 Q12025 Q22025 Q32025 Q42026 Q1
PeriodP/B
2026 Q13.27
2025 Q42.15
2025 Q32.38
2025 Q22.22
2025 Q12.04
2024 Q42.15
2024 Q31.84
2024 Q21.96
What is the EGEPO stock price?

The current price of EGEPO is 19.77 TRY. (2026-07-17)

What is the EGEPO E/P ratio?

The annual (TTM) E/P ratio of EGEPO is 0.0131. Market cap: 6.9B TRY.

What sector is EGEPO in?

EGEPO (NASMED ÖZEL SAĞLIK HİZMETLERİ TİCARET A.Ş.) operates in the Sağlık sector.

What is the EGEPO P/B ratio?

The P/B (Price-to-Book) ratio of EGEPO is 3.27.

EGEPO Stock Analysis — Borsa Istanbul

This page provides a comprehensive analysis of EGEPO (NASMED ÖZEL SAĞLIK HİZMETLERİ TİCARET A.Ş.), a company listed on Borsa Istanbul in the Sağlık sector. The current share price, daily percentage change, and trading volume are updated at the end of each trading session using official BIST data.

Momentum and Technical Indicators

Short-term and medium-term momentum indicators for EGEPO are calculated using 21-day and 63-day return windows. The 21-day Sortino ratio measures risk-adjusted performance by penalizing only downside volatility, providing a cleaner signal than standard deviation-based metrics. Annualized volatility and 252-day (one-year) momentum are also displayed to help investors assess both trend strength and risk characteristics of EGEPO relative to its sector peers.

Fundamental Metrics

Key valuation ratios include the Earnings-to-Price (E/P) ratio calculated on both quarterly and trailing twelve-month (TTM) bases, the Price-to-Book (P/B) ratio derived from the most recent balance sheet equity, and market capitalization. Financial health indicators such as ROE (Return on Equity), ROA (Return on Assets), net profit margin, gross margin, and debt-to-equity ratio are sourced from the latest disclosed quarterly financial statements filed with KAP (Public Disclosure Platform).

Sector Comparison

EGEPO is compared against other stocks in the Sağlık sector across momentum, valuation, and profitability dimensions. The sector comparison table ranks EGEPO against its peers using percentile scores, making it easy to identify whether the stock is relatively cheap (high E/P), growing faster (high momentum), or more profitable (high ROE) compared to the sector median. All data is refreshed daily and financial ratios are updated each quarter after earnings disclosures.

This page does not constitute investment advice. All information is for educational and analysis purposes.